The infectious diseases pharmacist: An essential partner for health-system leadership in keeping pace with the coronavirus disease 2019 (COVID-19) pandemic

National survey study of nirmatrelvir-ritonavir prescribing processes and access barriers during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron surge of the coronavirus disease 2019 (COVID-19) pandemic

“…These findings are consistent with previously published studies describing the role of pharmacists in the COVID-19 pandemic response. 8,9 In addition, our survey revealed that pharmacists were more likely be involved with individual assessments at facilities that adopted centralized prescribing strategies, highlighting their important responsibility within multidisciplinary clinics for tasks such as medication reconciliation and assessment of drug-drug interactions. The unique role of pharmacists in handling Paxlovid has since been recognized through expansion of its EUA to allow direct prescribing by pharmacists.…”